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In Brief
He et al. describe an integrated transcriptional map of lncRNA networks at multiple stages during oligodendrocyte lineage progression and reveal a key lncRNA epigenetic circuitry through interaction with chromatin-modifying complexes in control of CNS myelination and myelin repair.
INTRODUCTION
Myelination in the CNS by oligodendrocytes (OLs) is required for rapid propagation of action potentials. Defects in myelin repair impair brain functions and contribute to inherited and acquired neurological diseases, such as leukodystrophies and devastating multiple sclerosis (MS) (Mar and Noetzel, 2010; Trapp et al., 1998) . Despite the presence of oligodendrocyte precursor cells (OPCs), myelination fails to proceed in demyelinating lesions in MS patients (Chang et al., 2002) . At present, the factors that promote the initiation of OPC differentiation and overcome the block for successful remyelination in demyelinating diseases are poorly defined. OL lineage development can be orchestrated by extrinsic and intrinsic cues and coordination of genetic and epigenetic regulators, including transcription factors, chromatin remodelers, and small non-coding RNAs, that activate the myelinogenic program while suppressing differentiation inhibitory pathways (Emery and Lu, 2015; Zuchero and Barres, 2013) .
Both human and mouse genomes encode thousands of long noncoding RNAs (lncRNAs) of greater than 200 nt. These lncRNAs are frequently polyadenylated and transcribed by RNA polymerase II, and have no coding potential (Guttman et al., 2009) . lncRNAs have been implicated in the regulation of both normal development (Batista and Chang, 2013; Fatica and Bozzoni, 2014) and diseases (Bhan and Mandal, 2014; Lalevé e and Feil, 2015) . Recent work points to the critical role of lncRNAs in transcriptional and post-transcriptional control of gene expression, the formation of complexes with epigenetic regulatory machinery, and chromosomal architecture organization (Quinn and Chang, 2016; Rinn and Chang, 2012) .
Whether lncRNAs are responsible for OL myelination in a temporally specific manner during development and remyelination is unknown. Although studies have shown expression of lncRNAs during CNS development (Mercer et al., 2010; Ramos et al., 2013) and in OPCs (Dong et al., 2015) , a mechanistic understanding of the functions of lncRNAs in myelinogenesis in the CNS remains elusive. Identification and characterization of lncRNAs during OL lineage progression are vital to our full understanding of the mechanisms of myelinogenesis and myelin repair in the CNS.
Herein, we provide the first all-inclusive lncRNA annotation and mapping in mouse OLs at different stages. We profiled (E) Box plot of tissue specificity index (Ts score) for mRNA and lncRNA genes. Ts scores are calculated by analysis of fractional expression in OLs across all the tissues examined. Whiskers show the minimum and maximum, and boxes extend from the first to the third quartiles, with cross lines at the medians; Student's t test with Welch's corrections. (F) Heat map representation of ChIP-seq signal density for H3K4me3, H3K27ac, and Sox10 for 5 kb centered on predicted lncRNA TSSs in rat OPCs and OLs. (G) Histogram depicting ChIP-seq signal density on all predicted lncRNA promoters for H3K27ac, H3K4me3, and Sox10 in primary rat OLs.
(legend continued on next page) dynamic lncRNA expression during OL lineage differentiation by utilizing paired-ended next-generation sequencing of RNA and de novo transcriptome reconstruction. Through gene co-expression network analysis, we defined a group of lncRNAs that are tightly associated with OL differentiation. Among these, we find that lncOL1, an OL-restricted lncRNA, is both crucial and sufficient for OPC differentiation as well as timely initiation of myelination and remyelination in the CNS. Furthermore, we found that lncOL1 interacts with Suz12 in the PRC2 complex to suppress OL differentiation inhibitory pathways. Collectively, our study provides a comprehensive mapping of lncRNAs in the OL lineage for elucidating the transcriptional and epigenetic regulation of myelinogenesis and demonstrates a critical role of lncRNA-mediated epigenetic regulation for OL differentiation and timely CNS myelination.
RESULTS

Comprehensive De Novo Mapping of lncRNAs during OL Lineage Progression
To gain insights into the functions for lncRNAs during OL development, we first set out to create an all-inclusive high-quality catalog of such transcripts using an ab initio transcriptome reconstruction pipeline (Trapnell et al., 2010 ) that incorporates evidence of RNA transcripts from a collection of RNA deepsequencing datasets from primary mouse OPCs and OLs that were differentiated with triiodothyronine (T3) for 1 day (iOL [immature OL]) and 3 days (mOL [maturing OL]) (Figures 1A and S1A, available online). To identify putative lncRNA genes, we selected transcripts that were longer than 200 nucleotides and multiexonic and that did not overlap with protein-coding genes on the same strand. We then removed transcripts with coding-potential assessment (CPAT) scores higher than 0.44, which has been shown to identify noncoding RNAs . The high stringency annotation revealed 2,392 lncRNA transcripts derived from 1,342 unique gene loci (named as lncOLs; Figure 1A ). Of these loci, 42% were not found in the Ensembl database ( Figure S1B ). They are located in intergenic regions or introns of well-defined genes ( Figures S1C and S1D) .
We next examined the expression patterns of lncOLs over a diverse panel of neural cell types (Zhang et al., 2014) , neuronal tissues, and other somatic tissues (Yue et al., 2014) . As previously reported (Trapnell et al., 2010) , the lncRNAs identified had very little protein-coding potential, as measured by the CPAT algorithm ( Figure 1B) . Additionally, lncRNA exons were less conserved than protein-coding exons, as shown by PhastCons scores ( Figure 1C) , and their average expression levels were lower than those of protein-coding genes in OL lineage cells ( Figure 1D ). We observed greater tissue specificity (Ts) of lncRNAs than of protein-coding genes ( Figures 1E and S1E) , which corroborates the notion that lncRNA expression is highly cell-type specific (Guttman et al., 2009) . Such analyses enabled us to identify a cohort of lncRNAs that are highly enriched in OL lineage cells ( Figure S1E ), including those transcribed from previously reported gene loci (Zhang et al., 2014 ) (e.g., lncOL1-3; Figure S1F ), which validates our approach, and previously unidentified lncRNAs from unannotated genomic loci (e.g., lncOL4-6; Figure S1G ).
lncRNAs Are Dynamically Regulated and Expressed during OL Lineage Progression To further characterize the lncRNA expression pattern, we analyzed transcription start site (TSS) regions for the presence of histone modification marks and transcription factor occupancy. In agreement with previous reports (Derrien et al., 2012) , a large majority of the promoters in the identified lncRNAs were associated with the transcription-activating histone marks H3K4me3 and H3K27ac ( Figure S2A ). More importantly, whereas lncRNAs evolve rapidly and often lack orthologs in other species (Diederichs, 2014) , we found that a significant portion of lncOLs is also present in the syntenic loci of rat OL lineage cells, evident by the enrichment of H3K4me3 and H3K27ac in conserved genomic regions ( Figures 1F and 1G ), suggesting a functionally conserved role of these lncRNAs during OL development. In addition, genomic occupancy by Sox10, an OL-differentiation regulator (Lopez-Anido et al., 2015) , was detected at many putative lncRNA promoters in rat OLs ( Figures 1F and 1G ), suggesting that Sox10 transcriptionally regulates these lncRNAs.
By investigating the dynamics of lncRNA expression over the course of OPC differentiation and maturation, we identified a subset of lncRNAs that were differentially expressed between differentiating OLs and OPCs ( Figure 1H ). Furthermore, profiling analysis of lncRNA expression after contusive spinal cord injury in mice revealed that expression of a group of lncOLs, such as lncOL1, was reduced at 2 days post-lesion (dpl) and reactivated at 7 dpl during the regeneration process in the spinal cord (Figures S2B and S2C) , suggesting a potential importance of lncRNAs for OL regeneration, which diminishes during OL loss and conversely increases during differentiation.
Co-expression Networks between lncRNAs and ProteinCoding Genes in OLs
Expression of many lncRNAs is highly correlated with that of their protein-coding neighbors, and some lncRNAs influence the expression of nearby genes (Rinn and Chang, 2012) . However, Pearson coefficient estimation of neighboring pairs of lncRNAs and mRNAs revealed no obvious correlations, as a group, between the majority of lncOLs and adjacent mRNAs in the OL lineage ( Figures S2D and S2E ). This suggests that expression of the majority of lncOLs is not related to local transcriptional activity of neighboring protein-coding genes or involved in the same biological processes.
To assess the potential functions of lncOLs, we evaluated the co-relationship between lncOLs and protein-coding genes using the Markov clustering algorithm (MCL), which assigns genes into modules based on their similarity in expression patterns (van Dongen and Abreu-Goodger, 2012) . We identified 19 clusters contained at least 100 correlated lncRNAs and protein-coding genes ( Figure 1I ) that are associated with known biological processes. The lncRNA genes in MCL cluster I are primarily associated with neurogenesis and gliogenesis ( Figure 1J ). Assessment of the Pearson correlation between lncRNA and protein-coding genes within MCL cluster I revealed that this group of lncRNAs (e.g., lncOL1 and lncOL4) is highly correlated with the myelinogenic gene program, such as Mbp and Nkx2.2 ( Figures 1K and  S2F ), suggesting that this group of lncRNAs is likely involved in OL myelination.
Functional Characterization of OL-Enriched lncOLs in OPC Differentiation
Given that OL-enriched lncOLs were identified in our lncRNA de novo reconstruction and network analysis, we next sought to validate and characterize the expression and function of candidate lncOLs. We selected four lncRNAs from the cluster I lncRNA set for further analysis: lncOL1-3, three previously annotated but uncharacterized lncRNAs, and lncOL4, a previously unannotated lncRNA (Figure 2A ). LncOL1-4 are transcribed from genomic regions associated with active histone marks, including H3K4me4 and H3K27Ac (Figure 2A ). Despite cellular abundance to various extents, lncOL1-4 were robustly expressed in mouse CNS tissues, such as the brain and spinal cord, but were barely detectable in other somatic tissues ( Figure 2B ). Furthermore, concurrent with dynamic expression of OL differentiation regulators, such as Tcf7l2/Tcf4 , in the developing spinal cord, lncOL1-4 expression was detected at the neonatal stage postnatal day (P)0 and peaked at the perinatal stage P14, followed by a sharp decline in adulthood ( Figure 2C ). Consistently, lncOL1-4 were substantially upregulated during OPC differentiation in vitro ( Figure 2D ).
To determine lncOL1-4 function in OL differentiation, we attenuated their expression in primary OPCs using small interfering RNAs (siRNAs). Knockdown of lncOL1-4 individually inhibited expression of myelin genes, including Mbp, Plp1, and Cnp ( Figures 2E and 2F ), suggesting that induction of these lncRNAs is critical for proper OL differentiation in vitro. Next, we investigated whether the gain of function of lncOL1-4 could promote OL differentiation gene expression. To ensure proper processing and secondary structure formation, we cloned murine lncOL1-4 into the pBI-CMV3 vector to allow transcription of lncRNAs and a GFP reporter ZsGreen1 from constitutively active bidirectional human cytomegalovirus promoters (Figure 2G) . Forced expression of lncOL1, lncOL2, and lncOL4 led to a significant induction of differentiation-associated genes (e.g., Mbp, Mag, and Myrf), whereas lncOL3 exhibited minimal effects on promoting the OL differentiation program ( Figure 2G ).
LncOL1
Is an OL-Restricted lncRNA that Promotes OL Differentiation In Vivo Our ranking of oligodendrocytic lncRNAs by their abundance, regulation during the transition from OPC to OL, and potential functions identified lncOL1 as a top candidate modulator of OL differentiation. Analysis with the various coding-potential assessment tools, including CPAT , the Coding Potential Calculator (Kong et al., 2007) , and PhyloCSF (Lin et al., 2011) , indicated that the lncOL1 transcript has minimal, if any, protein-coding potential ( Figure S3A ).
In mouse and rat OL lineage cells, lncOL1 is located within the second intron of Pcdh17 and is actively transcribed in the direction opposite to Pcdh17 ( Figure 3A) . Peaks in genomic occupancy by Sox10 and Olig2, two critical OL transcriptional regulators, were observed near the lncOL1 TSS in rat OLs. Occupancy of activating histone marks H3K4me3 and H3K27ac as well as Olig2 was markedly enhanced around the TSS of lncOL1 in differentiating OLs relative to OPCs ( Figure 3A) , suggesting greater chromatin accessibility and transcription activity at the lncOL1 promoter during OL differentiation. lncOL1 expression is restricted to OL lineage cells because transcripts of lncOL1 were not detected in other neural cell types, such as neural progenitor cells and astrocytes ( Figure 3A ). In addition, human brain tissues and glioma cells, but no other tissue types, exhibited an enrichment of active promoter-associated H3K4me3 on the predicted TSS of the putative human lncOL1, indicating potentially conserved expression of lncOL1 in the human brain ( Figure S3B ).
In line with the enhancement of activating histone marks at the lncOL1 promoter, lncOL1 transcript levels were substantially induced during OL differentiation, along with Mbp and Myrf in culture ( Figure 3B ). In situ hybridization revealed prominent expression of lncOL1 in CNS white matter tracts in the brain and spinal cord of mice at perinatal stages (Figures 3C and 3D) . lncOL1 was expressed exclusively in a subset of Olig2 + OL lineage cells ( Figure 3E ). Moreover, lncOL1 was co-expressed in cells that expressed the mature OL markers CC1 and Sip1/Zeb2 (Weng et al., 2012) (Figure 3E ), but was barely detected in PDGFRa + OPCs ( Figure 3E ). Taken together, our data indicate that lncOL1, an evolutionally conserved lncRNA, is restricted to differentiating OLs in the OL lineage ( Figure S3C ).
RNA fluorescence in situ hybridization (FISH) showed that lncOL1 transcripts were detected in both the cytoplasm and nucleus of OPCs, but were enriched in the nuclear fraction and formed multiple ''foci'' in the nucleus of differentiating OLs (Figure 3F ). Consistently, cell fractionation of oligodendroglial cell line Oli-Neu cells (Ljungberg et al., 1995) followed by qRT-PCR demonstrated that the nuclear fraction of lncOL1 was associated with chromatin ( Figure S3D ), suggesting a potential role of the lncOL1 transcript in transcriptional regulation during OL differentiation.
Given that siRNA-mediated silencing of lncOL1 significantly inhibited myelin gene expression ( Figures 2E and 2F ), we then evaluated the functional role of lncOL1 in OL maturation. We attenuated lncOL1 expression by transduction of OPCs with a lentiviral vector for expression of small hairpin RNAs (shRNAs) designed to target lncOL1 ( Figure S3E ). OPCs with lncOL1 knockdown exhibited a defect in differentiation into MBP + OLs (Figures 3G and 3H) . Next, we investigated whether the gain of function of lncOL1 could promote precocious OL formation in vivo. Electroporation of the lncOL1-expressing vector pBI-lncOL1 carrying a GFP reporter ( Figure 3I ) into the cortical ventricular zone of developing embryos at E14.5 led to the precocious formation of MBP + OLs that expressed Olig2 at E17.5 ( Figures 3J and 3K ), at which stage no MBP + OLs are observed in the control cortex. These observations suggest that enforced expression of lncOL1 in neural progenitors induces OL differentiation in the cortex.
Loss of lncOL1 Leads to Defects in OL Differentiation and Myelination Onset In Vivo
To investigate the functional requirement for lncOL1 in OL development in vivo, we generated lncOL1-knockout (KO) mice using CRISPR-Cas9 technology (Doudna and Charpentier, 2014) . Two (legend continued on next page) pairs of single guide RNAs (sgRNAs) were designed to delete a 5.7-kb region covering the first four exons of lncOL1 ( Figure 4A ). Pups from the F0 generation were screened for indels and confirmed by Sanger sequencing of potential off-target sites. A founder carrying a monoallelic deletion was chosen and backcrossed with wild-type mice for three generations. lncOL1-KO mice were born at expected Mendelian ratios from heterozygous intercrosses ( Figure 4B ). qRT-PCR confirmed the loss of transcripts of lncOL1-containing regions targeted for deletion in brain tissues of homozygous mutant mice ( Figure 4C ). Levels of transcripts containing the 3 0 non-deleted regions of lncOL1 were also substantially downregulated ( Figure 4C) .
When the developing spinal cords at P1 were analyzed, the percentage of CC1 + differentiating OLs among Olig2 + OL lineage cells was significantly lower in lncOL1-KO mice than in control littermates ( Figures 4D and 4E) . Similarly, expression of MBP, a mature OL marker, was reduced in the lncOL1-KO brain compared to controls (Figures 4F and 4G) . In contrast, the total numbers of PDGFRa + OPCs were comparable between control and lncOL1-KO animals ( Figure 4H ). These observations suggest that lncOL1 is crucial for timely OPC differentiation, but not their formation. Strikingly, ultrastructural analysis of optic nerves from lncOL1-KO mice at the onset of myelination, e.g., P9 showed severe defects in myelinogenesis, with essentially an absence of myelinated axons ( Figures 4I and 4K ). At postnatal week 3, e.g., P17, the peak period of myelinogenesis, the number of myelinating axons had increased in lncOL1-KO mice relative to P9 but was still less than that in control mice ( Figures 4J and 4K) . Notably, the myelin sheaths (as measured by g-ratio, the ratio of the diameter of the axon to the diameter of the axon plus its myelin sheath) were significantly thinner in lncOL1 mutant optic nerves than in controls ( Figure 4L ). At adulthood, however, the number of mature OLs and degree of myelination were indistinguishable between adult lncOL1-KO and control mice ( Figure S4 ). Collectively, these observations indicate that lncOL1 regulates the timing of OL differentiation and the onset of myelination, but not myelin maintenance.
To determine whether defects in OL maturation in lncOL1-KO animals are cell autonomous due to lncOL1 deletion, we cultured OPCs isolated from control and lncOL1-KO neonates and analyzed their capacity to proliferate and to differentiate in vitro. In the presence of mitogen PDGFAA, lncOL1-KO OPCs were able to proliferate as they expressed the proliferative marker Ki67 (Figures 4M and 4N) . In contrast to efficient differentiation of control OPCs into CNP + and MBP + OLs upon treatment with T3, lncOL1-KO OPCs exhibited significant deficits in their capacity to differentiate into mature OLs ( Figures 4O and 4P ), suggesting lncOL1 null OPCs are intrinsically defective in differentiation and maturation.
LncOL1 Is Critical for Proper OL Remyelination after Demyelination lncOL1 transcription was reactivated during the subacute phases of spinal cord injury ( Figure S2B ). We then hypothesized that lncOL1 might participate in myelin repair. To test this hypothesis, we injected lysolecithin (LPC) into the white matter of adult control and lncOL1-KO mice at P60 when the numbers of myelinated axons and myelin morphology were comparable between lncOL1-KO and wild-type animals ( Figure S4 ). Focal injection of LPC induces rapid myelin breakdown followed by myelin regeneration (Franklin and Ffrench-Constant, 2008) . In normal adult spinal white matter, expression of lncOL1 was hardly detectable; however, lncOL1 levels were increased over the course of remyelination following LPC-induced demyelination ( Figures 5A-5C ).
To determine the potential role of lncOL1 in OL remyelination, we examined the re-appearance of myelin genes and OLs in the lesion during regeneration processes. At 14 dpl, we observed an increase of myelin genes Cnp, Plp1, Mag, or CC1 + OLs in control animals, whereas expression of these myelin genes and the number of CC1 + OLs were substantially reduced in lncOL1 mutants ( Figures 5D-5G ). In contrast, loss of lncOL1 did not appear to impair the recruitment of PDGFRa + OPCs because numbers of OPCs in lesions were comparable between control and lncOL1 null animals ( Figures 5H and 5I ). Ultrastructural analysis indicated that there were far fewer myelinated axons in the lesions of lncOL1-KO mice than in controls ( Figures 5J and 5K ). In addition, newly generated myelin sheaths around axons at 14 dpl were substantially thinner in lncOL1-KO mutants than in controls ( Figure 5L ). Thus, these observations suggest that lncOL1 is crucial for the OL remyelination process, but not OPC formation, in the context of white matter injury.
lncOL1 Interacts with the Suz12/PRC2 Complex to Control OL Differentiation Program Certain lncRNAs have been shown to regulate gene expression through interactions with specific protein partners (Hajarnis et al., 2015; Maass et al., 2014) . To identify potential lncOL1-interacting proteins, we adopted a sequence-based RNA-protein interaction prediction algorithm catRAPID (Bellucci et al., 2011) and identified a cohort of candidate lncOL1-interacting partners ( Figure S5A ). Among the candidates was Suz12, a component of polycomb repressive complex 2 (PRC2). PRC2 is an epigenetic regulator that participates in transcriptional repression by catalyzing histone H3 trimethylation (Conway et al., 2015) . The canonical PRC2 complex consists of Eed, Suz12, and the histone methyltransferase Ezh2, which is required for PRC2 activity.
To test whether lncOL1 and Suz12 form a ribonucleoprotein complex, we transiently transfected HEK293T cells with plasmids expressing lncOL1 RNA and hemagglutinin (HA)-tagged Suz12 and performed RNA immunoprecipitation using an antiSuz12 antibody. lncOL1 was present in the Suz12 immunocomplex, but the control, Gapdh mRNA, was not ( Figure 6A ). Furthermore, biotin-labeled full-length lncOL1 RNA, but not control RNA, robustly enriched Suz12 protein from cell lysates of 293T cells that overexpress Suz12 ( Figure 6B ). More importantly, the lncOL1-Suz12 interaction was further confirmed by pulling (legend continued on next page) down endogenous Suz12 in primary oligodendrocytes and analyzing co-purified RNA by qRT-PCR. lncOL1 was specifically enriched in Suz12 immunoprecipitates compared to the control RNA ( Figure 6C ). In addition, we found that Suz12 was precipitated with biotin-labeled lncOL1, but not by biotin-labeled control RNA from extracts of oligodendroglial Oli-Neu cells (Figure 6D) . Similarly, RNA immunoprecipitation assays indicated that lncOL1 was enriched in the complex pulled down with Suz12, Eed, and Ezh2 from Oli-neu cells under differentiation conditions ( Figure 6E ). These protein-RNA interaction studies suggest that lncOL1 and Suz12/PRC2 form a complex in OLs.
Cooperation of lncOL1 and Suz12-PRC2 Complex Regulates OPC Differentiation Suz12 was mainly detected in both PDGFRa + OPCs and CC1 + oligodendrocytes in the spinal white matter at P14 ( Figure 6F ). Intriguingly, whereas Suz12 and Ezh2 protein levels were slightly downregulated during OPC differentiation in vitro, H3K27me3 levels substantially increased as OLs became mature, similar to that of lncOL1 transcripts ( Figure 6G ). This observation points to a possible involvement of lncOL1 and Suz12-mediated gene silencing during OL maturation. To evaluate the functional role of the Suz12-PRC2 complex, we knocked down Suz12 and Eed expression in mouse OPCs using retrovirally expressed shRNAs (Shi et al., 2013 ) ( Figure 6H Figure 6M ). Consistently, interference of Ezh1/2 enzymatic function by the small molecule inhibitor Unc1999 (Konze et al., 2013) diminished the induction of myelin-associated genes (Mbp, Plp1, Mag, Cnp, and Myrf) in a dose-dependent manner ( Figures S5D  and S5E ). Together, these data suggest that Suz12-PRC2 activity is required for OPC maturation.
To further investigate the cooperativity between lncOL1 and Suz12-PRC2 during OL differentiation, we overexpressed lncOL1 in OPCs in the presence of siRNAs against Suz12 or the Ezh1/2 inhibitor Unc1999. We found that the enhancement of OL differentiation ( Figures 6N and 6O ) and myelination-associated gene expression ( Figures 6P and 6Q ) driven by lncOL1 overexpression were overridden by the loss of Suz12 expression or PRC2 enzymatic activity. These observations suggest that the lncOL1-regulated OL differentiation process requires the presence of the Suz12-PRC2 complex.
LncOL1 Acts as a Modulatory Factor for Suz12 to Silence the OPC-Enriched Gene Program during OL Differentiation
To investigate the mechanism underlying lncOL1 functions in OPC differentiation, we performed transcriptome profiling analysis of gene expression alteration in differentiating OLs between lncOL1-KO and control OPCs under differentiation conditions. Nuclear lncRNAs can exert regulatory functions in cis or in trans during cell differentiation (Ulitsky and Bartel, 2013) . lncOL1 is localized in the second intron of the protein-coding Pcdh17 gene; however, expression of Pcdh17 was not significantly correlated with expression of lncOL1, whereas lncOL1 is correlated with the myelin gene Plp1 (Figures S6A and S6B ). Furthermore, Pcdh17 transcript levels were not affected by lncOL1 knockdown ( Figure S6C ), and deletion of the lncOL1 genomic locus did not influence the expression of Pcdh17 or other genes within 10 Mb of the lncOL1 locus ( Figures S6D and S6E ), indicating that lncOL1 likely exerts its regulatory functions in trans.
Consistent with an impaired OL differentiation phenotype, lncOL1 deletion caused a reduction in expression of OL-enriched genes (gene module I) and an increase in expression of OPC-enriched genes (gene module II) (Zhang et al., 2014) (Figures 7A and 7B) . Intriguingly, promoters of upregulated genes in OPC-enriched module II exhibited lower levels of active histone modifications, such as H3K27ac and H3K4me3 than those in OL-enriched module I ( Figure 7C ), suggesting that lncOL1 antagonizes the transcriptional program that maintains OPC state while activating OL differentiation programs. Consistently, gene ontology (GO) analysis revealed that the genes downregulated in lncOL1 null OLs are associated with myelination, cytoskeletal organization, and glial cell differentiation, whereas genes upregulated in lncOL1 null cells are linked to cell growth, proliferation, and neurogenesis ( Figures 7D and 7E) . Furthermore, RT-PCR analysis confirmed a substantial reduction in mRNAs encoding myelin structural markers (e.g., Mbp and (legend continued on next page) Plp1), regulators of lipid metabolisms (e.g., Pik3r3 and Elovl1), and proteins involved in cytoskeleton organization (e.g., Gjc2, Tppp, and Matp7) in lncOL1 null OLs compared to controls (Figure 7F) . Intriguingly, we did not observe a substantial increase of OPCs in lncOL1 mutants (data not shown), suggesting that lncOL1 ablation does not block but delays the transition from OPC to OL. Thus, these observations indicate that lncOL1 orchestrates the balance necessary between transcriptional programs to permit OL differentiation. Given the upregulation of the OPC-associated transcriptional program in the absence of lncOL1, we hypothesize that lncOL1 may cooperate with a Suz12-mediated repressive complex to silence the expression of OPC-enriched genes. Chromatin immunoprecipitation sequencing (ChIP-seq) analyses revealed that Suz12 was essentially excluded from H3K27ac-enriched enhancers and promoters in OPCs ( Figure 7G ). Furthermore, expression of Suz12-targeted genes was downregulated substantially as compared to those without proximal Suz12 binding in OLs ( Figure 7H ), suggesting that Suz12 silences the transcription of OPC-enriched genes by deposition of repressive H3K27me3 marks on their enhancers and promoters.
To elucidate whether lncOL1 influences Suz12 function, we assessed the expression of Suz12-targeted genes in differentiating OLs derived from control and lncOL1-KO OPCs. Gene set enrichment analysis (GSEA) demonstrated that the levels of genes targeted by Suz12 were significantly increased in lncOL1-KO cells ( Figure 7I ), suggesting that lncOL1 loss leads to a general de-repression of Suz12-targeted genes. lncOL1-Suz12 target gene sets (genes upregulated in lncOL1 null cells with promoters occupied by Suz12) are associated with cell growth and proliferation, and their expression is enriched in OPCs ( Figure 7J ). These include Igf2, which encodes insulinlike growth factor 2 that promotes OPC growth and proliferation (Frederick and Wood, 2004; Zhang et al., 2010) , H19, which is an imprinted lncRNA that promotes progenitor cell proliferation (Ratajczak, 2012) , and Cyp1b1, which encodes the cytochrome P450 family protein that enhances cell proliferation and tumorigenesis (Mitsui et al., 2015) (Figure 7K ). These genes are highly expressed in OPCs, but strongly repressed during OL maturation ( Figures S6F and S6G) (Dugas et al., 2006; Zhang et al., 2014) , suggesting that their expression maintains OPCs in the precursor state. Furthermore, qRT-PCR analyses indicated that expression of these genes was significantly induced in lncOL1 null OPCs and in cells in which Suz12 expression was silenced ( Figures 7L and 7M ). Because lncOL1 depletion had no effect on PRC2 core subunit expression ( Figure S6H ), we then asked whether the induction of Suz12-targeted genes in lncOL1 null OLs is due to alteration of Suz12 recruitment. To test this hypothesis, we performed ChIP followed by qPCR (ChIP-qPCR) for Suz12 in mouse OLs from control and lncOL1-deficient mice. Suz12 occupancy was enriched at the promoter of Igf2, H19, and Cyp1b1 in OLs ( Figure S6I ). However, it was markedly reduced in the absence of lncOL1 ( Figure 7N ), suggesting that lncOL1 is crucial for Suz12 recruitment on the targeted promoters in OLs. Collectively, these observations indicate that lncOL1 interacts with Suz12 to promote OL differentiation by promoting the deposition of Suz12 at its targeted gene loci.
DISCUSSION Dynamic Landscape and Functional Networks of lncRNAs during OL Lineage Progression
Decoding regulatory elements and factors that control OL myelination is important for identifying new therapeutic targets to treat demyelinating disorders. Our study presents the first integrated transcriptional map, to our knowledge, of lncRNA elements at multiple stages during OL lineage progression, and defines the association of distinct OL-expressing lncRNA clusters with corresponding protein-coding genes.
(D) Immunoblot for endogenous Suz12 in differentiating Oli-Neu cells after RNA pull-down with biotin-labeled lncOL1 or biotin-labeled control RNA (Bmp4). Pulldown by streptavidin beads without RNA probe as a negative control. The larger band appeared as a non-specific protein associated with beads. (E) qRT-PCR quantification of lncOL1 and Gapdh in Suz12, Eed, and Ezh2 immunoprecipitates using RNA immunoprecipitation (RIP) assay from differentiating oligodendroglial cells (Oli-Neu). Data are presented as mean ± SEM; n = 3 to 4 independent experiments. *p < 0.05, **p < 0.01; Student's t test. (F) P14 mouse spinal cord transverse sections immunostained for Suz12, CC1, and PDGFRa. Scale bar, 100 mm. Boxed area is shown at higher magnification on right; scale bar, 20 mm. By integrative analyses of transcriptome profiling and genome-wide chromatin states, we systematically constructed and cataloged lncRNAs that are actively transcribed during OL differentiation. Previously, studies used the public datasets of poly-A(+) non-stranded RNAs to identify lncRNAs in OPCs (Dong et al., 2015) and glial cell differentiation from mixed neural progenitors using a microarray platform (Mercer et al., 2010) . The lncRNAs annotated in the present de novo annotation not only include lncRNAs previously annotated, but also identify over 500 unique, previously un-annotated lncRNAs that are enriched during OL differentiation. lncRNA expression profiling at multiple phases during OL differentiation and regeneration after spinal cord injury revealed that transcription of lncRNAs, like mRNAs, is dynamically regulated during development and repair. Our analyses reveal tissue and temporal specificity and genetic diversity of complex lncOLs, which allow fine mapping the dynamic processes and functions of lncRNAs in OL development and demyelinating diseases.
The unmapped nature of lncRNAs and their interaction with protein-coding genes during OL lineage progression has represented a substantial obstacle to the full delineation of the transcriptional and epigenetic network that regulates stepwise myelinogenesis. The reconstruction of a conserved co-expression network that links lncRNAs with protein-coding gene expression and their functions allows identifying the potential functions of lncRNAs during OL lineage progression and remyelination.
LncOL1 Is Both Sufficient and Crucial for the Timely Initiation of OL Differentiation and Myelination
The functions of the vast majority of lncRNA transcripts are currently unknown. We identify that lncOL1 is an evolutionally conserved and OL-restricted lncRNA. Enforced expression of lncOL1 induces precocious OL formation in the developing brain. Inhibition of lncOL1 by siRNA silencing in vitro and CRISPR-mediated targeting in vivo establish a critical role of lncOL1 for the timely initiation of OL myelination. Although myelination recovery is observed in the adult lncOL1 null mice, this may indicate the functional redundancy of other factors. Indeed, additional silencing of other lncOLs in lncOL1 knockout OPCs led to a further downregulation of myelin genes in vitro (Figure S7A) . Therefore, OL differentiation can proceed at later stages in the absence of lncOL1, but at a suboptimal level. The requirement of lncOL1 for the timely myelination onset is consistent with its upregulation in newly formed myelinating OLs. lncOL1 may act as a transiently expressed regulator to boost or accelerate the initiation of myelinogenesis, whereas it subsides when myelination falls into a steady maintenance phase in adulthood.
De novo transcriptome reconstruction reveals a cohort of previously un-annotated OL-enriched lncRNAs, including lncOL4, which regulates myelin gene expression ( Figure 2F) . Intriguingly, the miR219-2 gene is located within the intron of lncOL4. Given that lncOL4 knockdown leads to a downregulation of miR-219 and that the potential regulatory region of miR-219 is present in lncOL4 ( Figures S7B and S7C) , the function of lncOL4 in OL differentiation is likely channeled through the control of miR-219, a critical regulator of OL differentiation (Dugas et al., 2010; Zhao et al., 2010) . Together, these data suggest that lncRNAs are not simply transcriptional noise resulting from stochastic promoter firing, but rather play an important role in OL differentiation and myelinogenesis, and that individual lncRNAs likely regulate OL differentiation through distinct mechanisms.
LncOL1
Cooperates with a Chromatin-Remodeling Factor Suz12 to Antagonize the Gene Program that Maintains the OL Progenitor State Epigenetic regulation plays an important role in OL development and myelination (Emery and Lu, 2015) . Recent studies have shown that deposition of repressive H3K27me3 marks by the PRC2 complex increases during OL differentiation and contributes to the terminal differentiation of myelinating OLs (Liu et al., 2015; Sher et al., 2012) . Our study revealed that lncOL1 directly interacts with Suz12, a core component of the PRC2 complex for (F) qRT-PCR analyses of genes involved in different regulatory arms of OL differentiation. Data are presented as mean ± SEM; n = 3; *p < 0.05, ***p < 0.001; Student's t test. (G) ChIP-seq density heat maps for Suz12 and H3K27ac within 2.5 kb on either side of the Suz12 and H3K27ac peak centers in OPCs. The sites are ranked in descending order of Suz12 intensity. (H) Box plots for log 2 fold change in expression levels of the genes targeted with or without Suz12 in NFOs and myelinating OLs (MOs) (Zhang et al., 2014) compared to OPCs. (I) Gene signature enrichment analysis plot comparing the Suz12-targeted genes (top 500 genes with Suz12-binding peak within ± 50 kb around TSS) in wild-type or lncOL1-KO mouse OLs. NES, normalized enrichment score. FDR, false discovery rate. (J) GO biological process terms enriched among mRNA genes that are targeted by Suz12, with significantly higher expression levels in lncOL1 null OLs. (K) Genome browser tracks over select gene loci with ChIP-seq density mapping of Suz12, H3K27ac, and H3K4me3 from rat OLs. (L) qRT-PCR analyses of Cyp1b1, H19, and Igf2 in control and lncOL1-KO OLs. Data are presented as mean ± SEM; n = 3 independent experiments, ***p < 0.001; Student's t test. (M) qRT-PCR analyses of Suz12, Cyp1b1, H19, and Igf2 in primary mouse OLs treated with scrambled or Suz12-targeted siRNAs. Data are presented as mean ± SEM; n = 5 independent experiments. **p < 0.01; Student's t test. (N) ChIP-qPCR analyses for Suz12 at the promoters of Igf2, H19, and Cyp1b1 loci or control genomic regions (NC) in primary mouse OLs from control and lncOL1 knockout animals. Data are presented as mean ± SEM; n = 3 independent experiments. ***p < 0.001; Student's t test. (O) Schematic diagram for the lncOL1-mediated control of OL differentiation. When lncOL1 expression is turned on, it associates with Suz12-mediated PRC2 complex and silences the OPC gene regulatory program that antagonizes their differentiation process, and thereby allows the activation of the OL differentiation program. When lncOL1 expression is off, the OPC-promoting gene program is de-repressed and activated, which inhibits OL differentiation processes. Other lncRNAs may cooperate with lncOL1 to regulate the OL differentiation process. In box plots (B), (C), and (H), whiskers show the minimum and maximum, and boxes extend from the first to the third quartiles, with cross lines at the medians; Mann-Whitney-Wilcoxon test.
H3K27 methylation. We demonstrated that the Suz12-PRC2 complex is required for OL differentiation through transcriptional silencing of OPC-enriched gene clusters. More importantly, lncOL1-driven OL differentiation was diminished by the loss of Suz12 or PRC2 activity, supporting that lncOL1 exerts its regulatory function through Suz12.
Transcriptome profiling of lncOL1 null OLs indicated that lncOL1 perturbation resulted in a derepression of Suz12 target genes in a trans-regulatory manner, suggesting that lncOL1 is crucial for the repressive activity of the PRC2 complex on Suz12 target gene expression. We further found that lncOL1 interacts with Suz12 to form a repressor complex to silence gene transcription through implementing repressive H3K27me3 marks on gene regulatory elements. Although further studies will be required to fully elucidate the mechanism behind lncOL1 function, our work suggests that lncOL1 promotes OL differentiation, in part, by modulating the recruitment of Suz12 to silence the OPC-enrichment network. Thus, the lncOL1 interaction with Suz12 forms a repressor complex to control the balance between OPC maintenance and OL differentiation ( Figure 7O ), suggesting an important role of the interplay between lncRNAs and histone-modifying enzymes in OL development.
lncRNAs in Myelin Repair
Functional studies of lncRNAs in cardiac and liver regeneration indicate that lncRNAs, like microRNAs (miRNAs), likely act as fine-tuning factors that enable cells and organs to respond to stress, injury, and chronic disease (Lorenzen and Thum, 2016) . In line with this, our study demonstrates that expression of lncRNAs is dynamically regulated across remyelinating phases. In particular, we showed that lncOL1 is reactivated and critical for robust OL regeneration after demyelinating injury. The crucial role of lncOL1 in the regulation of timely OL differentiation and remyelination highlights a therapeutic potential of lncRNAs as a molecular therapy to enhancing myelin regeneration. Given the unique expression pattern of individual lncRNAs in the OL lineage, modulation of OL-restricted lncRNA expression will not impact other cell types and would provide unique therapeutic avenues for promoting myelin repair in demyelinating diseases, with lower odds of side effects.
EXPERIMENTAL PROCEDURES
Full details are provided in the Supplemental Experimental Procedures. Complete protocols are available upon request from Q.R.L.
Animals
All animal studies were approved by the Institutional Animal Care and Use Committees of the Cincinnati Children's Hospital Medical Center. Further details are described in the Supplemental Experimental Procedures.
Primary OPC Isolation and Culture Primary rat OPCs were isolated and cultured as described previously (Chen et al., 2007) . Mouse OPCs were isolated from P5-P6 cortices by immunopanning, as previously described (Yu et al., 2013) . Rat OPCs were transfected with expression vectors or siRNAs using Amaxa Nucleofector (Lonza) according to the manufacturer's protocol. The detailed information for cell culture, immunocytochemistry, qRT-PCR, and western blotting and co-immunoprecipitation assays are described in the Supplemental Experimental Procedures.
lncRNA Assembly and Annotation Mouse OPCs and OLs were sequenced (paired-end stranded-specific, 80-90 million reads/sample) in duplicates for ab initio transcriptome assembly with Cufflinks v2.2.1. Briefly, Cufflinks was run with the following options: -u, -N, -g (mm10 GTF file provided as guide), and -M (rRNA and 7SK RNA mask file provided). We generated transcriptome assemblies for each of these samples separately and then used Cuffmerge to combine all annotations. For all subsequent filtering and processing steps, please see the Supplemental Experimental Procedures.
RNA-Seq and Data Analysis
Total RNA was extracted from samples using the RNeasy Plus mini kit (Life Technologies). The resulting RNA samples were then used as input for library construction with TruSeq Stranded mRNA Library Prep Kit, according to the manufacturer's instructions. All RNA-seq data were aligned to mm10 using TopHat v2.1.0 with default parameters. We used Cuffdiff v1.3 for all differential expression (DE) analyses with our custom annotation containing RefSeq entries plus OL-expressing lncRNAs, as described below. In all DE tests, a gene was considered significant if the fold change was more than 1.5 and the q value was less than 0.05.
ChIP-Seq and Data Analysis
ChIP assays were performed in rat OPCs with antibody against Suz12 (Cell Signaling Technology, #3737), as previously described (Yu et al., 2013) . For details, see the Supplemental Experimental Procedures. Sequencing data were aligned to March 2012 rat genome assembly (rn5) using Bowtie with the following options: -p 8 and -m 1. Resulting SAM files were converted to BAM format using SAM tools. Peak calling was performed using MACS (Model-Based Analysis of ChIP-Seq), with a p value cut off of 1 3 e 9 .
Statistical Analysis All analyses were done using GraphPad Prism 6.00. Data are shown as mean ± SEM or as a box and whisker plot. Data distribution was assumed to be normal, but this was not formally tested. Statistical significance was determined using two-tailed Student's t tests or Wilcoxon rank-sum and signed-rank tests, as indicated. A one-way ANOVA test was performed by multiple comparisons. Significance was set as *p < 0.05, **p < 0.01, and ***p < 0.001, unless otherwise indicated. No statistical methods were used to predetermine sample sizes, but our sample sizes are similar to those reported in previous publications. Quantifications were performed from at least three independent experiments. Lysolecithin-induced demyelinating injury was performed in a double-blinded fashion.
ACCESSION NUMBERS
The accession number for the RNA-seq, ChIP-seq data, and lncRNA annotation reported in this paper is GEO: GSE82211. 
SUPPLEMENTAL INFORMATION
